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Abstract
Purpose: This study aimed to assess whether the benefits of exercise on central adiposity and insulin resistance (HOMA-IR) are maintained after
discontinuation of intervention in the overweight/obese (OWOB) women.
Methods: The study subjects were from 2 independent studies with similar aerobic exercise (AE) intervention programs. In study I, 15 OWOB
postmenopausal women with pre-diabetes (body mass index, BMI = 24–33 kg/m2, aged 52–65 years) completed an 8-month exercise intervention
and were followed for 2 years after the intervention. In study II, 12 OWOB (BMI = 25–35 kg/m2, aged 30–50 years) premenopausal women
participated in a 6-week AE and were followed for 4 years after the intervention. The exercise program consisted of progressive AE with intensity
of 60%–75% of initial fitness level, 30–60 min/time and 3–5 times/week. Fat mass (FM) was assessed by Dual Energy X-ray Absorptiometry
(DXA Prodigy; study I) or bioelectrical impedance device (Inbody 720; study II). Plasma glucose and insulin were assessed by chemiluminescent
immunoassay and HOMA-IR was calculated.
Results: Both 8-month and 6-week moderate AE were effective in reducing HOMA-IR (−18.9%, p = 0.012 and −26.7%, p = 0.046, respectively),
and 8-month AE reduced FM at upper abdominal region (−6.2%, p = 0.021). However, these improvements were not maintained in either study
at the follow-up.
Conclusion: The AE program used in these studies was effective to reduce insulin resistance and/or FM in central body region among overweight
and obese women. However, when exercise intervention was discontinued, the beneficial effects following both short- and long-term intervention
disappeared. Thus maintaining exercise seems to be required if one wants to reap the benefits of exercise in the long-term.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
The current public health burdens caused by chronic disease
cluster are associated with sedentary lifestyle and unbalanced
diet.1 Studies have shown that increasing individual levels of
physical activity (PA) by exercise intervention is effective for
reducing insulin resistance2–5 and adiposity;6,7 especially among
populations with sedentary lifestyle and obesity.7 However, such
studies are still facing the challenge in terms of whether the
subjects would maintain the PA level after the discontinuation of
the organized exercise and whether the benefit gained from exer-
cise intervention remained after intervention over time.
To date, the results of whether the benefit from exercise
could remain after exercise intervention are still inconclusive.
Some studies have shown that lifestyle intervention including
exercise can prevent or delay progression to type 2 diabetes,4–12
and that effects persist even after the intervention is
stopped.10–12 These positive results are mainly from long-term
interventions. However, other studies showed that the partici-
pants who initially lost weight following lifestyle interventions
gradually regained weight by the end of intervention.7,13 One of
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the main reasons for the loss of the health benefits from exercise
is that weight loss is in a dose–response of exercise fashion.14
One study has shown that more than half of the obese and
diabetes patients involved in an exercise program did not main-
tain the same level of PA at 6 months after the intervention.15 A
decrease of exercise is accompanied with weight regain, even
for those who have previously succeeded in loss their weight
over time.16 Therefore, relationships between organized exer-
cise interventions, their cessation, and the maintenance (or lack
of) long-term health benefits remain incompletely defined.
The present report aimed to address the following issue: when
considering “Exercise is Medicine” for diseases such as impaired
glucose metabolism, can the benefit of “Exercise is Medicine” on
insulin resistance and central adiposity be maintained after dis-
continuation of interventions during prolonged follow-up? We
reported outcomes based on 2 different studies. Both studies had
used same exercise type and intensity; however with different
duration of intervention in overweight/obese (OWOB) women.
2. Methods
2.1. Subjects
The study subjects were from 2 independent studies with
similar aerobic exercise (AE) intervention program that were
introduced elsewhere.17,18 Briefly, for the purpose of this report,
only those in the exercise group with both pre-intervention and
follow-up assessment results were included. Study I included
15 OWOB postmenopausal women (body mass index,
BMI = 24–33 kg/m2, aged 52–65 years) with pre-diabetes who
have completed an 8-month exercise intervention and followed
for 2 years. Study II consisted of 12 OWOB premenopausal
women (BMI = 25–35 kg/m2, aged 30–50 years) participated in
a 6-week AE and followed for 4 years after onset of interven-
tion. Studies I and II were approved by the Ethics Committee of
Shanghai Institute of Nutrition (No. 2013–003) and the Ethical
Committee of Central Finland Health Care District (7/2011
OTE), respectively. Written informed consents were obtained
from all subjects prior to the assessments.
2.2. Background information
Background information including medical history, current
health status, and level of PA was collected via self-
administered questionnaires and was described elsewhere.17,18
For this report, the level of PA in terms of hours and times per
week was only considered unsupervised exercises because sub-
jects participating in supervised exercise sessions was similar.
The inactivity (IPA) was defined as amount of hours spent
sitting and lying down including sleep per day.
2.3. Anthropometry and fat mass (FM)
Anthropometry and body composition were assessed in the
morning after 12-h fasting. Height was determined using a
wall-fixed measuring device, and body mass using a calibrated
scale, and from these, BMI was calculated. In study I, a dual-
energy X-ray absorptiometry (DXA Prodigy; GE Lunar Corp.,
Madison,WI, USA) was used to estimate FM of the whole body
and abdominal android and gynoid regions. Precision of the
repeated measurements of FM expressed as coefficient of varia-
tion was on average 2.2%. In study II, a bioelectrical impedance
analysis device (Inbody 720; Biospace Co. Ltd., Seoul, Korea)
was used for determining FM. Precision of the repeated mea-
surements of FM expressed as coefficient of variation was on
average 0.6%.
2.4. Insulin resistance
Venous blood samples were taken in standardized fasting con-
ditions at 7:00–8:00 a.m. Plasma samples were used to assess
glucose and insulin and explained in previous papers.17,18 The
homeostasis model assessment of insulin resistance (HOMA-IR)
index was calculated as (fasting insulin concentration × fasting
glucose concentration)/22.5.19
2.5. Exercise intervention
Both studies used the same exercise program.17 Specifically,
for exercise intervention, supervised exercise program (mainly
aerobic exercise such as Nordic walking plus stretching and
other group exercise) based on the recommendation for seden-
tary adults was implemented.20 The supervised exercise
program was progressive and variable and was monitored by an
exercise researcher for 2 times a week during the course of the
study. The other 1–3 times of unsupervised exercise sessions
were performed by participants themselves according the
instruction. The intensity of exercise was increased from 60%
to 75% of the maximum oxygen uptake (estimated from fitness
test) and the duration of exercise was increased from 30 to
60 min per session, and the frequency from 3 to 5 times a week.
The exercise intensity was monitored by using heart rate
monitor (M5; Suunto, Vantaa, Finland) in each supervised exer-
cise session and monthly 1 time during unsupervised sessions.
The exercise protocol was updated weekly in study I17 and
monthly in study II.18
3. Results
In study I, the changes of unsupervised participation in
PA/IPA in terms of hours and times per week and hours per
week in sitting and lying down, and body weight and FM are
shown in Table 1. The unsupervised exercise sessions signifi-
cantly increased during intervention (p < 0.01) but reduced
after the discontinuation of intervention. When taking into
account the supervised sessions, the amount of exercise
decreased after intervention at the 2 years follow-up. During the
intervention, 61.5% of the subjects increased the amount of
unsupervised exercise and the remaining 38.5% did not change.
After intervention, only 53.8% maintained their exercise par-
ticipation as during intervention and the other 46.2% decreased
their exercise time and frequency.
There were no significant changes in body weight and whole
body and lower abdominal FM. Interestingly, the upper abdomi-
nal FM at the android region decreased significantly after inter-
vention (−6.1%, p = 0.021) but regained during the follow-up
(12.8%, p < 0.01, Fig. 1D). The HOMA-IR decreased signifi-
cantly after intervention (−18.9%, p = 0.012) but attenuated
during the follow-up (5.0%, p > 0.05, Fig. 1C).
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A similar pattern was found in study II that after a short-term
of 6-week AE, no significant changes were found in body
weight and FM (Table 1), while HOMA-IR significantly
decreased (−26.7%, p = 0.046, Fig. 2), but the benefit relapsed
after 4 years (no significant difference between baseline and at
the 4-year follow-up).
4. Discussion
Previous studies have shown that AE has not only a direct
impact on body composition and weight6,7 but also affects
insulin resistance.2–4 The results of the current report were in
line with these studies. Our study further showed that in
pre- or postmenopausal women, both short- and long-term
AE were effective to improve the insulin resistance without
significant change in body weight. In the long-term exercise
intervention, body FM was lost from upper abdominal region.
However, all the benefits were lost after discontinuation of the
intervention. Thus the “medical effect” of AE on glucose
metabolism13 and reduction of central adiposity6,21 would
vanish if the “exercise medication” is stopped.
In study I, with 8-month AE intervention and 2-year follow-
up, over 60% of the participants increased their amount of
exercise time and frequency during intervention regardless of
the supervised part of exercise sessions, while about half of the
participants decreased their amount of exercise time and fre-
quency after intervention. The reduction in amount of exercise
is likely to be the main reason for the relapsing of the benefits
from exercise in insulin resistance and regain in central adipos-
ity. Previous studies showed that more than half of the subjects
Table 1
Body weight, fat mass, and physical activity/inactivity during aerobic exercise intervention and follow-up.
Study I (n = 15) Study II (n = 12)
Baseline Intervention Follow-up Baseline Intervention Follow-up
Weight (kg) 69.9 ± 6.4 68.8 ± 6.4 69.5 ± 6.1 79.7 ± 9.1 79.2 ± 9.1 79.5 ± 10.0
BMI (kg/m2) 27.6 ± 2.6 27.2 ± 2.6 27.3 ± 2.6 28.1 ± 2.1 28.0 ± 2.0 28.1 ± 2.4
FM (kg) 26.1 ± 4.1 25.2 ± 4.0 25.5 ± 3.8 22.5 ± 1.2 22.3 ± 1.2 22.5 ± 1.4
IPA (h/day) 14.4 ± 2.7 15.5 ± 2.8 15.5 ± 3.0 16.5 ± 3.8 — 16.6 ± 3.1
PA (times/week) 1.67 ± 0.98 3.40 ± 1.40** 3.00 ± 1.40 2.15 ± 0.75 — 2.71 ± 0.85
PA (h/week) 1.70 ± 1.10 3.10 ± 1.80** 2.50 ± 1.80 2.90 ± 0.97 — 3.48 ± 1.25
Notes: Study I = 8-month aerobic exercise and 2-year follow-up; Study II = 6-week aerobic exercise and 4-year follow-up.
** p < 0.01, compared with baseline values.
Abbreviations: BMI = body mass index; FM = fat mass; IPA = physical inactivity; PA = physical activity.
Fig. 1. Comparison of glucose (A), insulin resistance (B–C), and central adiposity (D) during 8-month aerobic exercise intervention and 2-year follow-up in
overweight/obese postmenopausal women with pre-diabetes (mean ± SD). HOMA-IR = homeostasis model assessment of insulin resistance; FMAndroid = upper
abdominal fat mass at the android region. *p < 0.05, compared with baseline; #p < 0.01, compared with 8-month intervention.
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did not maintain their level of PA after exercise interventions
stopped.15,16 Together, these results indicate that changing life-
style from sedentary to active and maintaining the active life-
style is needed to support long-term benefits.
The other interesting finding in the report is that there was no
significant weight loss in both studies. The body weight kept
relatively stable even after 4 years. Early study showed that a
short-term (4 weeks) AE decreased hepatic and visceral lipids
without weight loss in previously sedentary obese men and
premenopausal women.22 In our short-term exercise interven-
tion study, we did not measure the central abdominal fat mass,
thus we cannot know whether such short-term exercise could
reduce the central adiposity. However, with 8-month AE inter-
vention, central body FM declined significantly albeit without
noticeable changes in body weight and whole body FM. These
results indicate that short-term AE can mitigate metabolic risk
and it may not be contingent of weight loss. Nonetheless, the
regain of FMwas even more substantial with 12.8% regain after
intervention stopped. This observation is in agreement with a
previous study which showed that reduction of level of PA
would induce weight loss rebound.23
Despite similar observations from both studies, we acknowl-
edged the sample sizes for both studies are relatively small and
cannot entirely rule out type II error. However, the advantage of
this report lies on the fact that the studies’ subjects are from 2
completely populations. The results from one study could be
considered as validation for another study. In addition, the
exercise programs used in both studies are the same in type and
intensity albeit with different duration. This indicates that the
health benefit already can be reached even with a short-term of
6 weeks exercise, i.e., longer programs are not required to reap
benefits. This result, to some extent, could encourage partici-
pants to keep on with interventions since the most difficult
lifestyle intervention is sustaining in the beginning for
overweight/obese people.24 Nonetheless, as we have robustly
shown in the present 2 intervention/follow-up studies, mainte-
nance of PA long-term is needed to sustain these benefits.
To sum up, aerobic exercise is effective to reduce insulin
resistance and central body FM without noticeable whole body
weight loss (albeit some shifts in body composition with
long-term AE). However, when exercise is discontinued, the
beneficial effects are lost both short-term in premenopausal and
long-term in postmenopausal women. Thus maintaining exer-
cise seems to be required if one wants to reap the benefits of
exercise in the long-term.
Acknowledgments
This study was financially supported by the China State
Sport General Administration (No. 2013B040, 2015B039), the
University of Jyväskylä Wellness program and the Shanghai
Jiao Tong University Zhiyuan Foundation (No. CP2014013).
We would like to thank the researchers involved in both studies
for their valuable work and technical assistance on this project.
Authors’ contributions
SL conceived of and designed the experiments, performed the
experiments, analyzed the data, contributed reagents/materials/
analysis tools, and drafted the manuscript. LM conceived of and
designed the experiments, performed the experiments, and
drafted the manuscript. DL conceived of and designed the
experiments and performed the experiments.YY performed the
experiments, analyzed the data and contributed reagents/
materials/analysis tools. XT performed the experiments, ana-
lyzed the data, and contributed reagents/materials/analysis tools.
PW performed the experiments and analyzed the data. SC con-
ceived of and designed the experiments, performed the experi-
ments, analyzed the data, and drafted themanuscript.All authors
have read and approved the final version of the manuscript and
agree with the order of presentation of the authors.
Competing interests
None of the authors declare competing financial interests.
References
1. Halpin HA, Morales-Suárez-Varela MM, Martin-Moreno JM. Chronic
disease prevention and the new public health. Public Health Rev
2010;32:120–54.
2. Kadoglou NPE, Iliadis F, Sailer N, Athanasiadou Z, Vitta I, Kapelouzou A,
et al. Exercise training ameliorates the effects of rosiglitazone on
traditional and novel cardiovascular risk factors in patients with type 2
diabetes mellitus. Metabolism 2010;59:599–607.
Fig. 2. Comparison of glucose (A) and insulin resistance (B–C) during 6-week aerobic exercise intervention and 4-year follow-up in overweight/obese
premenopausal women (mean ± SD). HOMA-IR = homeostasis model assessment of insulin resistance. *p < 0.05, compared with baseline value.
169Benefits of aerobic exercise relapsed after intervention stopped
3. Desch S, SonnabendM, Niebauer J, Sixt S, SarebanM, Eitel I, et al. Effects
of physical exercise versus rosiglitazone on endothelial function in
coronary artery disease patients with prediabetes. Diabetes Obes Metab
2010;12:825–8.
4. Sénéchal M, Slaght J, Bharti N, Bouchard DR. Independent and combined
effect of diet and exercise in adults with prediabetes.Diabetes Metab Syndr
Obes 2014;7:521–9.
5. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H,
Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in
lifestyle among subjects with impaired glucose tolerance. N Engl J Med
2001;344:1343–50.
6. Yaffe MJ. Adiposity changes after a 1-year aerobic exercise intervention
among postmenopausal women: a randomized controlled trial. Int J Obes
(Lond) 2010;35:427–35.
7. Sarwer DB, Amy VSG, Vetter ML, Wadden TA. Behavior therapy for
obesity: where are we now? Curr Opin Endocrinol Diabetes Obes
2009;16:347–52.
8. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V.
The Indian Diabetes Prevention Programme shows that lifestyle
modification and metformin prevent type 2 diabetes in Asian Indian
subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:
289–97.
9. Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle
intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract
2005;67:152–62.
10. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE,
Hamman RF, Christophi CA, Hoffman HJ, et al. 10-year follow-up of
diabetes incidence and weight loss in the Diabetes Prevention Program
Outcomes Study. Lancet 2009;374:1677–86.
11. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term
effect of lifestyle interventions to prevent diabetes in the China Da Qing
Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008;371:
1783–9.
12. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö
K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle
intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet
2008;22:1673–9.
13. Sanz C, Gautier JF, Hanaire H. Physical exercise for the prevention and
treatment of type 2 diabetes. Diabetes Metab 2010;36:346–51.
14. Amati F, Barthassat V, Miganne G, Hausman I, Monnin DG, Costanza
MC, et al. Enhancing regular physical activity and relapse prevention
through a 1-day therapeutic patient education workshop: a pilot study.
Patient Educ Couns 2007;68:70–8.
15. King H, Kriska AM. Prevention of type II diabetes by physical training.
Epidemiological considerations and study methods. Diabetes Care
1992;15:1794–9.
16. McGuire MT,Wing RR, KlemML, LangW, Hill JO. What predicts weight
regain in a group of successful weight losers? J Consult Clin Psychol
1999;67:177–85.
17. Wiklund P, Alen M, Munukka E, Cheng M, Yu B, Pekkala S, et al.
Metabolic response to 6-week aerobic exercise training and dieting in
previously sedentary overweight and obese pre-menopausal women:
a randomized trial. J Sport Health Sci 2014;3:217–24.
18. Liu WY, Lu da J, Du XM, Sun JQ, Ge J, Wang RW, et al. Effect of aerobic
exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver
disease in postmenopausal women and middle aged men — the role of gut
microbiota composition: study protocol for the AELC randomized
controlled trial. BMC Public Health 2014;14:48. doi:10.1186/1471
-2458-14-4
19. Blomain ES, Dirhan DA, Valentino MA, Kim GW, Waldman SA.
Mechanisms of weight regain following weight loss. ISRN Obes
2013;2013:210524. doi:10.1155/2013/210524
20. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee
IM, et al., American College of Sports Medicine. American College of
Sports Medicine position stand. Quantity and quality of exercise for
developing and maintaining cardiorespiratory, musculoskeletal, and
neuromotor fitness in apparently healthy adults: guidance for prescribing
exercise. Med Sci Sports Exerc 2011;43:1334–59.
21. Friedenreich CM, Neilson HK, O’Reilly R, Duha A, Yasui Y, Morielli AR,
et al. Effects of a high vsmoderate volume of aerobic exercise on adiposity
outcomes in postmenopausal women: a randomized clinical trial. JAMA
Oncol 2015;1:766–76.
22. Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A,
Thompson MW, et al. Aerobic exercise training reduces hepatic and
visceral lipids in obese individuals without weight loss. Hepatology
2009;50:1105–12.
23. Jakicic JM, Marcus BH, LangW, Janney C. Effect of exercise on 24-month
weight loss maintenance in overweight women. Arch Intern Med
2008;168:1550–9, discussion 1559-60.
24. Yackobovitch-Gavan M, Steinberg DM, Endevelt R, Benyamini Y. Factors
associated with dropout in a group weight-loss programme: a longitudinal
investigation. J Hum Nutr Diet 2015;28(Suppl. 2):S33–40.
170 S. Le et al.
